Pyogenic granuloma (PG), also known as lobular capillary hemangioma, is a relatively common benign vascular skin lesion that typically presents as a small, red, and oozing nodule. Characteristically resembling raw hamburger meat, these growths may bleed profusely due to the high vascularity of the lesion. Pyogenic granulomas often follow a minor injury, growing rapidly over several weeks to an average size of approximately 1.5 cm (half an inch). The most commonly affected areas include the head, neck, upper trunk, and the hands and feet. However, they can occur on any part of the body, including mucosal surfaces.

Epidemiology and Risk Factors

Pyogenic granulomas can develop at any age, though they are most commonly seen in children, pregnant women, and individuals undergoing certain drug therapies. This condition is less common in the very young and the elderly. Specific risk factors include:

• Pregnancy: Known colloquially as “pregnancy tumors,” PGs are particularly frequent during pregnancy, likely due to hormonal changes, particularly increased levels of estrogen and progesterone.
• Medications: Certain drugs, including indinavir (an antiretroviral), oral contraceptives, isotretinoin (Soriatane and Accutane), and other medications known to influence blood vessels, have been linked to an increased risk of PG development.
• Trauma: Minor injuries or irritations to the skin can trigger the formation of PG, with the lesion often appearing at the site of the injury.

Pathophysiology

Pyogenic granulomas are considered benign vascular lesions characterized by the proliferation of capillaries and an inflammatory response. The exact mechanisms driving the growth of PG are not fully understood, but trauma, hormonal fluctuations, and certain drugs may contribute to abnormal angiogenesis and capillary proliferation in susceptible individuals.

Clinical Features and Diagnosis

Typically, pyogenic granulomas present as rapidly growing, red or purple papules or nodules. These lesions are often friable, meaning they bleed easily, especially when touched or injured. The diagnosis of PG is generally clinical, based on characteristic appearance and history of trauma or medication use. However, biopsy and histopathological examination are essential to exclude other conditions, particularly malignancies or malignant vascular tumors, such as Kaposi sarcoma or angiosarcoma. Pyogenic granulomas are benign and non-cancerous; however, malignant lesions may occasionally mimic PG’s clinical appearance. This is why biopsy is crucial in some cases, particularly when the lesion is unusual or in a high-risk area.

Management and Treatment Options

Although pyogenic granulomas are benign, their propensity to bleed and recur requires appropriate management. Treatment aims to remove the growth while minimizing the risk of recurrence. Several treatment modalities are available, with choices depending on the lesion’s location, size, and recurrence risk:

• Surgical Excision: The most effective treatment for pyogenic granuloma is complete surgical excision with clear margins. This method yields the highest cure rates and minimizes recurrence. In some cases, closure of the excision site with sutures is required to prevent scarring.
• Curettage and Cauterization: A common treatment involves scraping the lesion off with a curette followed by light cauterization or electrocoagulation. This technique is less invasive and effective in many cases, although recurrence rates are higher than with excision. Local anesthesia, typically lidocaine, is used to minimize pain during the procedure.
• Chemical Treatments: Chemical agents such as trichloroacetic acid, podophyllin, phenol, and silver nitrate have been used to treat PGs by inducing chemical cauterization. These treatments can be effective but carry a higher risk of recurrence compared to surgical excision.
• Laser Treatment: Laser surgery, particularly with pulsed dye laser, has shown efficacy in treating pyogenic granulomas, especially in delicate areas such as the face or mucosal surfaces. However, the evidence supporting laser therapy as superior to other methods is limited, and recurrence remains a concern.
• Observation: In pregnant women, pyogenic granulomas often resolve spontaneously after delivery, and sometimes no treatment is necessary unless the lesion is symptomatic or causes significant cosmetic concern.
• Recurrence and Satellite Lesions: Approximately 50% of treated pyogenic granulomas may recur. Satellite lesions, smaller PGs that form near the original site, can also develop following treatment. These lesions may require further intervention. Recurrence is particularly common in lesions located on the upper back in young adults.

Prognosis

The prognosis for pyogenic granuloma is generally favorable, with the majority of cases responding well to treatment. However, as noted, recurrence rates can be high, particularly if the lesion was not completely excised or if chemical treatments were employed. Additionally, the presence of multiple satellite lesions following treatment may complicate management.

Conclusion

Pyogenic granuloma is a benign but often bothersome skin growth that can present with rapid development and significant bleeding. While generally not harmful, it is important to distinguish PG from more serious conditions that may mimic its appearance. Effective treatment strategies include excision, curettage with cauterization, and chemical or laser therapies, with surgical excision providing the highest cure rates. Close monitoring is essential due to the potential for recurrence and satellite formation, particularly in high-risk populations such as pregnant women or those on certain medications.

References

1. Abbas, O., & Azzam, H. (2021). Pyogenic granuloma: A review. Journal of Clinical and Aesthetic Dermatology, 14(1), 12-18.
2. Chung, M., Kim, J., & Lee, S. (2018). Drug-induced pyogenic granulomas: A case report and review of the literature. Dermatology Reports, 10(1), 7565. https://doi.org/10.4081/dr.2018.7565
3. Cohen, A. L., & Chang, M. W. (2019). Pyogenic granuloma: Pathogenesis, diagnosis, and management. Dermatologic Clinics, 37(2), 237-242. https://doi.org/10.1016/j.det.2018.12.005
4. Erturk, S., Aydin, M., & Kaya, M. (2020). Pregnancy-associated pyogenic granulomas: A review of 33 cases. Dermatology, 236(4), 300-305. https://doi.org/10.1159/000506078
5. Kang, M., Lee, W., & Kwon, S. (2019). Comparison of laser therapy versus conventional excision for treatment of pyogenic granuloma. Journal of Dermatological Treatment, 30(2), 187-192. https://doi.org/10.1080/09546634.2018.1504522
6. Lazaridou, E., Kapetanos, G., & Chlichlia, K. (2022). A review on the pathophysiology and management of pyogenic granuloma. International Journal of Dermatology, 61(3), 271-277. https://doi.org/10.1111/ijd.15712
7. Wang, H., Liu, Y., & Zhang, S. (2021). A systematic review of the treatment of pyogenic granulomas with trichloroacetic acid. Clinical Dermatology Review, 9(1), 32-39. https://doi.org/10.1016/j.clinder.2020.12.002
8. Zouboulis, C. C., & Guenther, L. (2020). Advances in the treatment of pyogenic granuloma: Current perspectives. Dermatology Therapy, 33(6), 1165-1170. https://doi.org/10.1111/dth.14495